Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03686566 · ClinicalTrials.gov registry record
Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 84
- Enrollment target
NCT03686566: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT03686566 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03686566 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
To explore metabolic phenotypes of children with extra-cranial solid tumors and compare these with their histopathological and genetic alterations to discover potential novel biomarkers and therapeutic targets to improve outcomes in children with high risk disease.
Primary Outcome
Upon collection of tumor samples, they will be processed and analyzed with mass spectrometry to learn how the tumor processes the labeled glucose by assessing enrichment of metabolites to identify the active metabolic pathways in each tumor (metabolic phenotype)
Interventions
- DRUG 13C-glucose
- OTHER No glucose infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2018-11-16 |
| Est. Completion | 2024-01-26 |
What the finished NCT03686566 record still lists
NCT03686566 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which 13C-glucose is the first listed.
NCT03686566 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03686566 about?
NCT03686566 is a clinical study titled "Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]". To explore metabolic phenotypes of children with extra-cranial solid tumors and compare these with their histopathological and genetic alterations to discover potential novel biomarkers and therapeutic targets to improve outcomes in children with high risk disease.
What is the current status of trial NCT03686566?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2018-11-16. Estimated completion is 2024-01-26.
What interventions are being tested in trial NCT03686566?
The interventions under investigation include: 13C-glucose (DRUG), No glucose infusion (OTHER).
Who is sponsoring clinical trial NCT03686566?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI